Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivabradine and Exercise Tolerance in Heart Failure
NCT02086422Unknown
- Sponsor
- Leeds Teaching Hospitals NHS Trust
- Start
- Jul 2013
- Primary completion
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of ivabradine in chronic heart failure (CHF), sponsored by Leeds Teaching Hospitals NHS Trust. Primary endpoint: Exercise capacity at 24 months. Status: unknown.
02
Drugs
ivabradine
03
Conditions
chronic heart failure (CHF)
Beyond the preview
Go deeper on NCT02086422.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02086422.